Vicarious Surgical (RBOT) Return on Capital Employed (2021 - 2025)
Vicarious Surgical (RBOT) posted quarterly Return on Capital Employed of 174.52% for Q3 2025, down 8889.0% year-over-year from 1.99% in Q3 2024, and down 20.68% quarter-over-quarter from 144.61% in Q2 2025.
Vicarious Surgical (RBOT) Return on Capital Employed (2021 - 2025) Analysis & Trends
Vicarious Surgical (RBOT) has reported Return on Capital Employed for 5 consecutive years, with 174.52% the latest figure, recorded in Q3 2025.
- In Q3 2025, Return on Capital Employed fell 8889.0% year-over-year to 174.52%; the TTM figure through Sep 2025 stood at 174.52% (down 8889.0% YoY), while the FY2024 annual figure was 77.28%, down 1159.0% from the prior year.
- Return on Capital Employed fell to 174.52% in Q3 2025 per RBOT's latest filing, from 144.61% in the prior quarter.
- Across five years, Return on Capital Employed topped out at 5.52% in Q2 2021 and bottomed at 174.52% in Q3 2025.
- Historically, Return on Capital Employed has averaged 68.0% across 5 years, with a median of 67.97% in 2023.
- Annual changes were most pronounced in 2024 — Return on Capital Employed surged 542 bps — and 2025, when it slumped 8889 bps.
- Vicarious Surgical's Return on Capital Employed stood at 21.09% in 2021, then slumped by 177 bps to 58.41% in 2022, then dropped by 16 bps to 67.97% in 2023, then plunged by 47 bps to 100.08% in 2024, then sank by 74 bps to 174.52% in 2025.
- Business Quant data shows RBOT's Return on Capital Employed at 174.52% in Q3 2025, 144.61% in Q2 2025, and 123.65% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | 7.98% |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | 13.69% |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 8.02% |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | 10.83% |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | 11.99% |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | 27.21% |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | 9.47% |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | 12.84% |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | 12.08% |
| 10 | Vicarious Surgical | 196,495.36 | -14.84 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -174.52% |
| Jun 30, 2025 | -144.61% |
| Mar 31, 2025 | -123.65% |
| Dec 31, 2024 | -100.08% |
| Sep 30, 2024 | -85.63% |
| Jun 30, 2024 | -76.75% |
| Mar 31, 2024 | -69.27% |
| Dec 31, 2023 | -67.97% |
| Sep 30, 2023 | -77.60% |
| Jun 30, 2023 | -82.17% |
| Mar 31, 2023 | -67.90% |
| Dec 31, 2022 | -58.41% |
| Sep 30, 2022 | -53.05% |
| Jun 30, 2022 | -38.57% |
| Mar 31, 2022 | -29.34% |
| Dec 31, 2021 | -21.09% |
| Sep 30, 2021 | -9.08% |
| Jun 30, 2021 | -5.52% |
| Mar 31, 2021 | -6.86% |